BWL
TEVA icon

Bogart Wealth LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Bogart Wealth LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339 Buy
+10
New +$333 ﹤0.01% 1857
2025
Q1 		– Sell
-77
Closed -$1.7K – 1509
2024
Q4 		$1.7K Buy
+77
New +$1.4K ﹤0.01% 1121

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bogart Wealth LLC's TEVA Position: Q2 2026 in Review

Bogart Wealth LLC opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 10 shares worth $339. The stake represents ﹤0.01% of the portfolio and ranks #1857 among its holdings. This is a return to the name: Bogart Wealth LLC previously reported a position in TEVA as recently as Q4 2024.

Bogart Wealth LLC first reported a position in TEVA in Q4 2024 and has held it in 2 quarters since. The position peaked at $1.7K in Q4 2024. 141 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bogart Wealth LLC held 10 shares of Teva Pharmaceuticals worth $339 as of Q2 2026.
  • Teva Pharmaceuticals was a new Bogart Wealth LLC position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1857 holding.
  • Bogart Wealth LLC first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
  • Bogart Wealth LLC's Teva Pharmaceuticals position peaked at $1.7K in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.